iPSC-Derived Immunotherapies Congress, on 18-19 October 2022 in Boston will highlight techniques used to develop safe, differentiated, and efficacious therapies to pass through regulatory hurdles. This event will be your opportunity to analyze developments in bringing iPSC-derived immunotherapies from bench to bedside to deliver long-lasting, safe, effective therapeutics.
Create a clear roadmap for clinical success with insights from industry leaders with advanced pipelines Ensure durability and avoid immune rejection through effective next-generation gene editing strategies Accelerate your IPSC-derived cell therapy manufacturing by establishing an automated, regulatory compliant manufacturing workflow Effectively navigate the regulatory requirements to bring IPSC-derived therapies into clinical trials with accelerated IND submission
Event Venue: Boston, Massachusetts
Event Date: 18-19 October, 2022
Event website: https://hubs.ly/Q01j6Hyk0
Event Organizer: Kisaco Research
Contact number: +44 (0)20 3696 2920
Email ID: marketing@kisacoresearch.com
